About the role
Our ambition is to be leaders in immunology across international markets and, Remibrutinib is at the core and center being a prioritized launch for the organization.
The Executive Director International, Remibrutinib, plays a pivotal role in leading the end-to-end brand strategy, encompassing the vision, development, orchestration, implementation, and evaluation of integrated Remibrutinib strategies across major international markets. As an enterprise leader, the ED will focus on the top three countries (Germany, Japan, and China) and Regions, driving the successful launch and growth of Remibrutinib, leading the launch of Hidradenitis Suppurative (HS) and supporting the launch of CSU among other LCMs.
The incumbent will collaborate closely with Global Drug Development (GDD), International Medical Affairs, Value & Access, and Customer & Market Activation teams to drive consistent strategy development and execution. This role represents the commercial team across different instances of the organization.
Key Responsibilities
Essential requirements:
Leadership Capabilities:
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? http://www.novartis.com/about/strategy/people-and-culture
Join our Novartis Network: Not the right Novartis role for you? Sign up to our talent community to stay connected and learn about suitable career opportunities as soon as they come up: http://talentnetwork.novartis.com/network
Benefits and Rewards: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: http://www.novartis.com/careers/benefits-rewards
Novartis is committed to building an outstanding, inclusive work environment and diverse teams' representative of the patients and communities we serve.